Literature DB >> 23490269

Tumour bed delineation for partial breast/breast boost radiotherapy: what is the optimal number of implanted markers?

Anna Nm Kirby1, Rajesh Jena, Emma J Harris, Phil M Evans, Clare Crowley, Deborah L Gregory, Charlotte E Coles.   

Abstract

PURPOSE: International consensus has not been reached regarding the optimal number of implanted tumour bed (TB) markers for partial breast/breast boost radiotherapy target volume delineation. Four common methods are: insertion of 6 clips (4 radial, 1 deep and 1 superficial), 5 clips (4 radial and 1 deep), 1 clip at the chest wall, and no clips. We compared TB volumes delineated using 6, 5, 1 and 0 clips in women who have undergone wide-local excision (WLE) of breast cancer (BC) with full-thickness closure of the excision cavity, in order to determine the additional margin required for breast boost or partial breast irradiation (PBI) when fewer than 6 clips are used.
METHODS: Ten patients with invasive ductal BC who had undergone WLE followed by implantation of six fiducial markers (titanium clips) each underwent CT imaging for radiotherapy planning purposes. Retrospective processing of the DICOM image datasets was performed to remove markers and associated imaging artefacts, using an in-house software algorithm. Four observers outlined TB volumes on four different datasets for each case: (1) all markers present (CT6M); (2) the superficial marker removed (CT(5M)); (3) all but the chest wall marker removed (CTCW); (4) all markers removed (CT(0M)). For each observer, the additional margin required around each of TB(0M), TBCW, and TB(5M) in order to encompass TB(6M) was calculated. The conformity level index (CLI) and differences in centre-of-mass (COM) between observers were quantified for CT(0M), CTCW, CT(5M), CT(6M).
RESULTS: The overall median additional margins required to encompass TB(6M) were 8mm (range 0-28 mm) for TB(0M), 5mm (range 1-13 mm) for TBCW, and 2mm (range 0-7 mm) for TB(5M). CLI were higher for TB volumes delineated using CT(6M) (0.31) CT(5M) (0.32) than for CTCW (0.19) and CT(0M) (0.15).
CONCLUSIONS: In women who have undergone WLE of breast cancer with full-thickness closure of the excision cavity and who are proceeding to PBI or breast boost RT, target volume delineation based on 0 or 1 implanted markers is not recommended as large additional margins are required to account for uncertainty over true TB location. Five implanted markers (one deep and four radial) are likely to be adequate assuming the addition of a standard 10-15 mm TB-CTV margin. Low CLI values for all TB volumes reflect the sensitivity of low volumes to small differences in delineation and are unlikely to be clinically significant for TB(5M) and TB(6M) in the context of adequate TB-CTV margins.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23490269     DOI: 10.1016/j.radonc.2013.02.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

1.  Displacement of the lumpectomy cavity defined by surgical clips and seroma based on 4D-CT scan for external-beam partial breast irradiation after breast-conserving surgery: a comparative study.

Authors:  Y Ding; J Li; W Wang; S Wang; T Fan; M Xu; Q Shao; Z Ma
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

Review 2.  Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.

Authors:  G G Hanna; A M Kirby
Journal:  Br J Radiol       Date:  2015-03-03       Impact factor: 3.039

3.  Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery.

Authors:  T Tse; S Knowles; J Bélec; J M Caudrelier; M Lock; M Brackstone; A Arnaout
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

4.  Dosimetric impact of tumor bed delineation variability based on 4DCT scan for external-beam partial breast irradiation.

Authors:  Bing Guo; Jianbin Li; Wei Wang; Fengxiang Li; Yanluan Guo; Yankang Li; Tonghai Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer.

Authors:  Sujievvan Chandran; Rhys Vaughan; Marios Efthymiou; Joseph Sia; Christopher Hamilton
Journal:  Endosc Int Open       Date:  2014-07-18

6.  Interobserver variability in the delineation of the tumour bed using seroma and surgical clips based on 4DCT scan for external-beam partial breast irradiation.

Authors:  Bing Guo; Jianbin Li; Wei Wang; Min Xu; Qian Shao; Yingjie Zhang; Chaoqian Liang; Yanluan Guo
Journal:  Radiat Oncol       Date:  2015-03-13       Impact factor: 3.481

7.  Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?

Authors:  Mariska D DEN Hartogh; Marielle E P Philippens; Iris E VAN Dam; Catharina E Kleynen; Robbert J H A Tersteeg; Alexis N T J Kotte; Marco VAN Vulpen; Bram VAN Asselen; Desirée H J G VAN DEN Bongard
Journal:  Oncol Lett       Date:  2015-09-14       Impact factor: 2.967

8.  A novel, adaptable, radiographically opaque, multi-plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow-up.

Authors:  Sunny Mitchell; Henry Lee; Beth Baughman DuPree; David C Beyer; Michael Ulissey; Stephen R Grobmyer; Jennifer Gass; Susan Boolbol; Toni Storm-Dickerson
Journal:  Gland Surg       Date:  2019-12

9.  A comparative study on the volume and localization of the internal gross target volume defined using the seroma and surgical clips based on 4DCT scan for external-beam partial breast irradiation after breast conserving surgery.

Authors:  Yun Ding; Jianbin Li; Wei Wang; Suzhen Wang; Jinzhi Wang; Zhifang Ma; Qian Shao; Min Xu
Journal:  Radiat Oncol       Date:  2014-03-19       Impact factor: 3.481

10.  Analysis of the variability among radiation oncologists in delineation of the postsurgical tumor bed based on 4D-CT.

Authors:  Wei Wang; Jianbin Li; Jun Xing; Min Xu; Qian Shao; Tingyong Fan; Bing Guo; Shanshan Liu
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.